Udredning og behandling af angst og depression hos patienter med KOL

Ida Stisen Fogh-Andersen, Ingeborg Farver-Vestergaard, Christian Møller Pedersen, Elisabeth Tehrani, Anders Løkke Ottesen*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Abstract

An estimated 33 percent of patients with COPD have co-morbidities in terms of anxiety and/or depression (A and D). A large proportion of these patients are not diagnosed, mainly because some of the core symptoms of A and D can be misinterpreted as being caused by COPD. Untreated A and D in patients with COPD can have a negative impact on several parameters e.g. dyspnoea and mortality. On this basis, this review argues, that special focus in primary care and hospitals on diagnosing and treating A and D in patients with COPD using anti-depressants or cognitive therapy can reduce symptom burden and significantly improve quality of life.

Bidragets oversatte titelExamination and treatment of anxiety and depression in patients with COPD
OriginalsprogDansk
ArtikelnummerV09200679
TidsskriftUgeskrift for Læger
Vol/bind183
Nummer4
Antal sider9
ISSN0041-5782
StatusUdgivet - jan. 2021

Emneord

  • Anxiety/diagnosis
  • Anxiety Disorders/diagnosis
  • Depression/diagnosis
  • Humans
  • Pulmonary Disease, Chronic Obstructive/complications
  • Quality of Life

Fingeraftryk

Dyk ned i forskningsemnerne om 'Udredning og behandling af angst og depression hos patienter med KOL'. Sammen danner de et unikt fingeraftryk.

Citationsformater